L S Elting

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi A systematic review of dental disease in patients undergoing cancer therapy
    Catherine H L Hong
    Department of Oral Medicine, Carolinas Medical Center, Charlotte, NC 28232, USA
    Support Care Cancer 18:1007-21. 2010
  2. ncbi Time to clinical response: an outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care
    L S Elting
    The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    J Clin Oncol 18:3699-706. 2000
  3. ncbi Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life
    Linda S Elting
    Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 113:2704-13. 2008
  4. ncbi Correlation between annual volume of cystectomy, professional staffing, and outcomes: a statewide, population-based study
    Linda S Elting
    Section of Health Services Research, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 104:975-84. 2005
  5. ncbi If at first you don't succeed, don't quit, try again: The Centers For Medicare and Medicaid Services demonstration project on quality of care--2005 and 2006
    Linda S Elting
    The University of Texas M D Anderson Cancer Center, Department of Biostatistics and Applied Mathematics, Section of Health Services Research, Houston 77030, USA
    J Support Oncol 4:147-51. 2006
  6. ncbi Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia
    Linda S Elting
    Department of Biostatistics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd Unit 447, Houston, TX 77030, USA
    J Clin Oncol 26:606-11. 2008
  7. ncbi Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants
    Linda S Elting
    Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 106:2452-8. 2006
  8. ncbi Psychosocial and economic impact of cancer
    Linda S Elting
    Section of Health Services Research, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 447, Houston, TX 77030, USA
    Dent Clin North Am 52:231-52, x. 2008
  9. ncbi Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results
    Linda S Elting
    Health Services Research, Department of Biostatistics, University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Biol Blood Marrow Transplant 13:806-13. 2007
  10. ncbi Mammography capacity impact on screening rates and breast cancer stage at diagnosis
    Linda S Elting
    Section of Health Services Research, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Am J Prev Med 37:102-8. 2009

Detail Information

Publications45

  1. ncbi A systematic review of dental disease in patients undergoing cancer therapy
    Catherine H L Hong
    Department of Oral Medicine, Carolinas Medical Center, Charlotte, NC 28232, USA
    Support Care Cancer 18:1007-21. 2010
    ....
  2. ncbi Time to clinical response: an outcome of antibiotic therapy of febrile neutropenia with implications for quality and cost of care
    L S Elting
    The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    J Clin Oncol 18:3699-706. 2000
    ..To determine whether antibiotic regimens with similar rates of response differ significantly in the speed of response and to estimate the impact of this difference on the cost of febrile neutropenia...
  3. ncbi Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life
    Linda S Elting
    Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 113:2704-13. 2008
    ..The risk, severity, and patient-reported outcomes of radiation-induced mucositis among head and neck cancer patients were prospectively estimated...
  4. ncbi Correlation between annual volume of cystectomy, professional staffing, and outcomes: a statewide, population-based study
    Linda S Elting
    Section of Health Services Research, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 104:975-84. 2005
    ..In the current study, the authors studied these associations, emphasizing hospital factors that contribute to the volume-outcome correlation...
  5. ncbi If at first you don't succeed, don't quit, try again: The Centers For Medicare and Medicaid Services demonstration project on quality of care--2005 and 2006
    Linda S Elting
    The University of Texas M D Anderson Cancer Center, Department of Biostatistics and Applied Mathematics, Section of Health Services Research, Houston 77030, USA
    J Support Oncol 4:147-51. 2006
  6. ncbi Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia
    Linda S Elting
    Department of Biostatistics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd Unit 447, Houston, TX 77030, USA
    J Clin Oncol 26:606-11. 2008
    ..We retrospectively compared the outcomes and costs of outpatient and inpatient management of low-risk outpatients who presented to an emergency department with febrile neutropenia (FN)...
  7. ncbi Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants
    Linda S Elting
    Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 106:2452-8. 2006
    ..The authors examined the comparability of clinical trial participants and nonparticipants and the potential impact of differences...
  8. ncbi Psychosocial and economic impact of cancer
    Linda S Elting
    Section of Health Services Research, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 447, Houston, TX 77030, USA
    Dent Clin North Am 52:231-52, x. 2008
    ....
  9. ncbi Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results
    Linda S Elting
    Health Services Research, Department of Biostatistics, University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Biol Blood Marrow Transplant 13:806-13. 2007
    ..In addition to its previously demonstrated clinical benefit, palifermin prophylaxis offers a favorable economic profile among patients with hematologic malignancies who receive total body irradiation and autologous stem cell support...
  10. ncbi Mammography capacity impact on screening rates and breast cancer stage at diagnosis
    Linda S Elting
    Section of Health Services Research, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Am J Prev Med 37:102-8. 2009
    ..S. reportedly is adequate, but has not been examined in nonmetropolitan areas. This study examined the relationships between in-county mammography facilities and rates of mammography screening and late-stage diagnosis of breast cancers...
  11. ncbi Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies
    Linda S Elting
    Section of Health Services Research, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 68:1110-20. 2007
    ..To study the risk, outcomes, and costs of radiation-induced oral mucositis (OM) among patients receiving radiotherapy (RT) to head and neck primary cancers...
  12. ncbi Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia
    L S Elting
    Department of Health Services Research, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 19:1137-46. 2001
    ..To describe the incidence and outcomes of bleeding and chemotherapy dose modifications associated with chemotherapy-induced thrombocytopenia (platelets < 50,000/microL)...
  13. ncbi Outcomes and costs of febrile neutropenia: adventures in the science and art of treatment choices
    Linda S Elting
    The University of Texas M D Anderson Cancer Center, Department of Biostatistics, Section of Health Services Research, 1515 Holcombe Boulevard, Box 196, Houston, Texas 77030 4009, USA
    Support Care Cancer 10:189-96. 2002
    ..The cost of therapy can be easily estimated by using the number and average cost of days of hospitalization as a surrogate. A decision-analytic model for febrile neutropenia is proposed...
  14. ncbi Cost of chemotherapy-induced thrombocytopenia among patients with lymphoma or solid tumors
    Linda S Elting
    The Section of Health Services Research, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 97:1541-50. 2003
    ..Another goal was to estimate the impact of depth and duration of thrombocytopenia on the cost of thrombocytopenia...
  15. ncbi The economic burden of supportive care of cancer patients
    Linda S Elting
    Department of Biostatistics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Support Care Cancer 12:219-26. 2004
    ..The goal of this study was to estimate these costs and to explore the impact of these costs on policy decisions...
  16. ncbi The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis
    Linda S Elting
    Section of Health Services Research, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston Texas 77030 4009, USA
    Cancer 98:1531-9. 2003
    ..Mucositis is a common but poorly studied problem among patients with solid tumors. The authors examined the clinical and economic outcomes of oral and gastrointestinal (GI) mucositis among patients receiving myelosuppressive chemotherapy...
  17. ncbi Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis
    Elenir B C Avritscher
    Section of Health Services Research, Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA
    Semin Oncol Nurs 20:3-10. 2004
    ..IMPLICATIONS FOR NURSING PRACTICE: An awareness of the risk factors associated with mucositis will allow nurses to identify cancer patients at greatest risk and incorporate supportive care measures into their management plans...
  18. ncbi In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample
    Jeffrey A Jones
    Health Services Research Section, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 112:1096-105. 2008
    ..Complications remain common, but population-based estimates of their frequency and relative contribution to cost are not available...
  19. ncbi Clinical model of cost of bladder cancer in the elderly
    Catherine D Cooksley
    Section of Health Services Research, Department of Biostatistics, University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Urology 71:519-25. 2008
    ..To develop a population-based clinical model of bladder cancer (BC) care costs and identify cost drivers...
  20. ncbi Cost-effectiveness of influenza vaccination in working-age cancer patients
    Elenir B C Avritscher
    Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 109:2357-64. 2007
    ..In the current study, the authors analyzed the cost-effectiveness of influenza vaccination in working-age (ages 20-64 years) cancer patients...
  21. ncbi Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy
    Ya Chen Tina Shih
    Section of Health Services Research, Department of Biostatistics, Division of Quantitative Sciences, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 110:678-85. 2007
    ..The objective of the project was to estimate the societal costs of uncontrolled CINV among working-age cancer patients...
  22. ncbi Hospitalizations for infection in cancer patients: impact of an aging population
    Catherine D Cooksley
    Department of Biostatistics, University of Texas M D Anderson Cancer Center Health Services Research, PO Box 301402 Unit 1409, Houston, TX 77030, USA
    Support Care Cancer 17:547-54. 2009
    ..The aim of this study was to assess the impact of an aging US population on inpatient costs and resource utilization in cancer patients admitted for infection...
  23. ncbi Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients
    Elenir B C Avritscher
    Division of Quantitative Sciences, Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77230, USA
    J Support Oncol 8:242-51. 2010
    ..The cost-utility of palonosetron-based therapy exceeds the $100,000/QALY threshold. Future research incorporating the price structure of all antiemetics following ondansetron's recent patent expiration is needed...
  24. ncbi Disparities in colorectal screening between US-born and foreign-born populations: evidence from the 2000 National Health Interview Survey
    Ya Chen Tina Shih
    Section of Health Services Research, Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Cancer Educ 23:18-25. 2008
    ..This study examines the disparities in colorectal cancer (CRC) screening between US- and foreign-born groups and explores factors associated with such disparities...
  25. ncbi Immunotherapy in the initial treatment of newly diagnosed cancer patients: utilization trend and cost projections for non-Hodgkin's lymphoma, metastatic breast cancer, and metastatic colorectal cancer
    Ya Chen Tina Shih
    Health Services Research, Department of Biostatistics, Division of Quantitative Sciences, The University of Texas M D Anderson Cancer Center, Houston, Texas 77230 1402, USA
    Cancer Invest 28:46-53. 2010
    ..3% MBC), immunotherapy was associated with $285, $73, and $12 million cost increase for NHL, MCRC, and MBC, respectively. Costs for these cancers would have exceeded $1.82 billion had 50% of eligible patients received immunotherapy...
  26. ncbi Gender and age differences in blood utilization and length of stay in radical cystectomy: a population-based study
    Marylou Cardenas-Turanzas
    Department of Biostatistics, Health Services Research, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd Unit 447, Houston, TX, 77030 4009, USA
    Int Urol Nephrol 40:893-9. 2008
    ..We evaluated resource utilization and complication rates of patients undergoing radical cystectomy or exenteration using the Texas Hospital In-Patient Discharge Data Collection...
  27. ncbi Factors associated with immunotherapy use among newly diagnosed cancer patients
    Ya Chen Tina Shih
    Section of Health Services Research, Department of Biostatistics, Division of Quantitative Science, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230, USA
    Med Care 47:948-58. 2009
    ..Immunotherapy represents a newer modality for cancer treatment with substantial health benefits. However, the high costs of immunotherapy may create access barriers...
  28. ncbi The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors
    Linda S Elting
    Section of Health Services Research, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 94:3252-62. 2002
    ..The authors developed a clinical prediction rule to guide the prophylactic use of platelet transfusions among patients with lymphoma or solid tumors...
  29. ncbi Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy
    Scott B Cantor
    Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer 97:3099-106. 2003
    ..The economic consequences of the routine use of this platelet growth factor and the usual standard of platelet transfusions for prophylaxis of severe chemotherapy-induced thrombocytopenia have not been compared...
  30. ncbi Outcomes and cost of deep venous thrombosis among patients with cancer
    Linda S Elting
    Section of Health Services Research, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston 77030 4009, USA
    Arch Intern Med 164:1653-61. 2004
    ..Furthermore, the cost of DVT is largely undescribed. We herein report the largest study of DVT in this population to date...
  31. ncbi Epidemiology and outcomes of serious influenza-related infections in the cancer population
    Catherine D Cooksley
    Section of Health Services Research, Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Cancer 104:618-28. 2005
    ..The current population-based study described the epidemiology and outcomes of potentially preventable, serious influenza-related infections in patients with cancer...
  32. ncbi Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer
    Jeffrey A Jones
    Section of Health Services Research, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston, USA
    Support Care Cancer 14:505-15. 2006
    ..Conclusions: Ongoing review of the clinical trial experience will remain important as newer, targeted agents enter standard clinical practice...
  33. ncbi Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules
    Kenneth V I Rolston
    Division of Internal Medicine, The University of Texas, M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 106:2489-94. 2006
    ..The objective of this study was to assess the feasibility of empiric, oral, outpatient quinolone monotherapy in 40 adult patients with fever and neutropenia who were at low risk for serious medical complications...
  34. ncbi Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study
    Ya Chen Tina Shih
    Section of Health Services Research, Department of Biostatistics, Division of Quantitative Sciences, The University of Texas M D Anderson Cancer Center, PO Box 301402, Houston, TX 77230 1402, USA
    J Clin Oncol 27:2007-14. 2009
    ..This study estimated the economic burden of breast cancer-related lymphedema (BCRL) among working-age women, the incidence of lymphedema, and associated risk factors...
  35. ncbi Does Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly?
    Ya Chen Tina Shih
    Section ofHealth Services Research, Department of Biostatistics and Applied Mathematics, M D Anderson Cancer Center, University of Texas, Houston, USA
    Health Aff (Millwood) 25:1153-62. 2006
    ..Overall, fewer than half of the elderly are screened, even though Medicare now covers colonoscopy...
  36. ncbi Clinical model of lifetime cost of treating bladder cancer and associated complications
    Elenir B C Avritscher
    Section of Health Services Research, Department of Biostatistics and Applied Mathematics, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Urology 68:549-53. 2006
    ..To estimate the lifetime cost of bladder cancer and the contribution of complications to the total costs...
  37. ncbi Measuring chemotherapy-induced nausea and emesis
    Charles G Martin
    Department of General Internal Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 98:645-55. 2003
    ..The psychometric properties of the new questionnaire show adequate reliability and validity to warrant its use in clinical trials and outcomes studies. CINE adversely affects many domains within a patient's QOL...
  38. ncbi Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis
    Elenir B C Avritscher
    Section of Health Services Research, Department of Biostatistics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard Unit 196, Houston, TX 77030 4009, USA
    Support Care Cancer 12:531-6. 2004
    ....
  39. ncbi Cost-effectiveness of the bird's nest filter for preventing pulmonary embolism among patients with malignant brain tumors and deep venous thrombosis of the lower extremities
    Quan Chau
    Section of Health Services Research, Department of Biostatistics, Section of Interventional Radiology, and Department of General Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA
    Support Care Cancer 11:795-9. 2003
    ..BNF was effective in reducing the rate of PE but was not cost-effective for patients with brain tumors. BNF could be cost-effective for patients with longer life expectancies...
  40. ncbi Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis
    Edward B Rubenstein
    Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    Cancer 100:2026-46. 2004
    ....
  41. ncbi Factors influencing the volume-outcome relationship in gastrectomies: a population-based study
    David L Smith
    Department of Surgery, Wilford Hall Medical Center, 2200 Bergquist Drive Ste 1, Lackland AFB, Texas 78236, USA
    Ann Surg Oncol 14:1846-52. 2007
    ..A relationship between hospital procedural volume and patient outcomes has been observed in gastrectomies for primary gastric cancer, but modifiable factors influencing this relationship are not well elaborated...
  42. ncbi Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients
    Stephen T Sonis
    Division of Oral Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Cancer 100:1995-2025. 2004
    ....
  43. ncbi Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries
    Jared R Adams
    Department of Veterans Affairs, the MidWest Center for Health Services and Policy Research and the Veterans Affairs Chicago Healthcare System/Lakeside Division, Chicago, Illinois, USA
    Am J Med 116:28-34. 2004
    ..01). CONCLUSION: Financial considerations and a hemoglobin level <10 g/dL appear to influence erythropoietin use in the United States, whereas financial considerations alone determine erythropoietin use abroad...
  44. ncbi Updated clinical practice guidelines for the prevention and treatment of mucositis
    Dorothy M Keefe
    Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, Australia
    Cancer 109:820-31. 2007
    ..These efforts are likely to have significant clinical and economic impact on the treatment of cancer patients. Cancer 2007;109:820-31. (c) 2007 American Cancer Society...
  45. ncbi Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment
    Cesar A Migliorati
    Department of Diagnostic Sciences, Nova Southeastern University College of Dental Medicine, Fort Lauderdale, FL 33328 2018, USA
    Lancet Oncol 7:508-14. 2006
    ..We also discuss pathobiology, clinical features, management, and future directions for the disorder...